𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase-I–II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas

✍ Scribed by B. Mascret; D. Maraninchi; J. A. Gastaut; D. Baume; G. Sebahoun; C. Lejeune; G. Novakovitch; D. Sainty; N. Horchowski; N. Tubiana; Y. Carcassonne

Publisher
Springer
Year
1985
Tongue
English
Weight
587 KB
Volume
14
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose melphalan, vincristine, and to
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: A phase II study
✍ Pinkerton, C. R. ;Philip, T. ;Biron, P. ;Frapazz, D. ;Phillipe, N. ;Zucker, J. M 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

Seven children with neuroblastoma who had relapsed on or after conventional therapy (3 originally stage IV, 3 stage III, 1 stage II) were entered on a study of "massive therapy" with purged autologous bone marrow rescue. In 5 patients attempts were made to reinduce remission with alternative chemoth

Intensive chemotherapy with high doses o
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies
✍ M. H. Gaspard; D. Maraninchi; A. M. Stoppa; J. A. Gastaut; G. Michel; N. Tubiana 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 688 KB

Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, thre

The feasibility of neoadjuvant high-dose
The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma : Results of a phase II study
✍ Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract ## BACKGROUND The primary and secondary objectives of the current study were to improve the ≥ 90% tumor necrosis rate and assess the toxicity profile of the neoadjuvant high‐dose chemotherapy (HDC) regimen, respectively. ## METHODS Twenty‐two patients with AJCC Stage IIB high‐grade o